Search hospitals > California > South San Francisco

Kaiser Permanente-South San Francisco

Claim this profile
South San Francisco, California 94080
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Breast cancer
179 reported clinical trials
8 medical researchers
Photo of Kaiser Permanente-South San Francisco in South San FranciscoPhoto of Kaiser Permanente-South San Francisco in South San FranciscoPhoto of Kaiser Permanente-South San Francisco in South San Francisco

Summary

Kaiser Permanente-South San Francisco is a medical facility located in South San Francisco, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Breast cancer and other specialties. Kaiser Permanente-South San Francisco is involved with conducting 179 clinical trials across 333 conditions. There are 8 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.

Area of expertise

1Skin Cancer
Global Leader
Kaiser Permanente-South San Francisco has run 68 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Kaiser Permanente-South San Francisco has run 45 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Kaiser Permanente-South San Francisco

Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Stomach Cancer
Esophageal cancer
Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Low Dose Tamoxifen

for Breast Cancer

This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Kaiser Permanente-South San Francisco?
Kaiser Permanente-South San Francisco is a medical facility located in South San Francisco, California. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Breast cancer and other specialties. Kaiser Permanente-South San Francisco is involved with conducting 179 clinical trials across 333 conditions. There are 8 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Natalya Greyz-Yusupov.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security